<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39358491</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>02</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Unraveling the pathogenic interplay between SARS-CoV-2 and polycystic ovary syndrome using bioinformatics and experimental validation.</ArticleTitle><Pagination><StartPage>22934</StartPage><MedlinePgn>22934</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">22934</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-74347-y</ELocationID><Abstract><AbstractText>The prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among polycystic ovary syndrome (PCOS) is significantly higher than in the general population. However, the mechanisms underlying this remain obscure. This study aimed to explore the mechanisms by identifying the genetic signature of SARS-CoV-2 infection in PCOS. In the present study, a total of 27 common differentially expressed genes (DEGs) were selected for subsequent analyses. Functional analyses showed that immunity and hormone-related pathways collectively participated in the development and progression of PCOS and SARS-CoV-2 infection. Under these, 7 significant hub genes were identified, including S100A9, MMP9, TLR2, THBD, ITGB2, ICAM1, and CD86 by using the algorithm in Cytoscape. Furthermore, hub gene expression was confirmed in the validation set, PCOS clinical samples, and mouse model. Immune microenvironment analysis with the CIBERSORTx database demonstrated that the hub genes were significantly correlated with T cells, dendritic cells, mast cells, B cells, NK cells, and eosinophils and positively correlated with immune scores. Among the hub genes, S100A9, MMP9, THBD, ITGB2, CD86, and ICAM1 demonstrated potential as possible diagnostic markers for COVID-19 and PCOS. In addition, we established the interaction networks of ovary-specific genes, transcription factors, miRNAs, drugs, and chemical compounds with hub genes with NetworkAnalyst. This work uncovered the common pathogenesis and genetic signature of PCOS and SARS-CoV-2 infection, which might provide a theoretical basis and innovative ideas for further mechanistic research and drug discovery of the comorbidity of the two diseases.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Bai</LastName><ForeName>Hai</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Applied Biotechnology, College of Agronomy and Life Science, Shanxi Datong University, Datong, 037009, Shanxi, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Shanshan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Biological Science, Jining Medical University, Rizhao, 276826, Shandong, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics Engineering, Xuzhou Medical University, Xuzhou, 221009, Jiangsu, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diao</LastName><ForeName>Kangyang</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Xuzhou Medical University, Xuzhou, 221009, Jiangsu, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Cui</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Physiology, School of Basic Medicine, Xuzhou Medical University, Xuzhou, 221009, Jiangsu, PR China. cui.li@xzhmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Experimental Teaching Demonstration Center for Basic Medicine, Xuzhou Medical University, Xuzhou, 221009, Jiangsu, PR China. cui.li@xzhmu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Mingming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Physiology, School of Basic Medicine, Xuzhou Medical University, Xuzhou, 221009, Jiangsu, PR China. wmm@xzhmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Experimental Teaching Demonstration Center for Basic Medicine, Xuzhou Medical University, Xuzhou, 221009, Jiangsu, PR China. wmm@xzhmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>KY13022201</GrantID><Agency>Natural Science Research of the Jiangsu Higher Education Institutions of China</Agency><Country /></Grant><Grant><GrantID>RC20552029</GrantID><Agency>Outstanding Talent Research Funding of Xuzhou Medical University</Agency><Country /></Grant><Grant><GrantID>82401923</GrantID><Agency>National Natural Science Foundation of China</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011085" MajorTopicYN="Y">Polycystic Ovary Syndrome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="Y">Computational Biology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053263" MajorTopicYN="N">Gene Regulatory Networks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Genetic signature</Keyword><Keyword MajorTopicYN="N">Immune microenvironment</Keyword><Keyword MajorTopicYN="N">Integrated bioinformatics</Keyword><Keyword MajorTopicYN="N">Polycystic ovary syndrome</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>23</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39358491</ArticleId><ArticleId IdType="pmc">PMC11448505</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-74347-y</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-74347-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Xu, M. et al. Effects of dietary grape seed proanthocyanidin extract supplementation on meat quality, muscle fiber characteristics and antioxidant capacity of finishing pigs. Food Chem.367, 130781. 10.1016/j.foodchem.2021.130781 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34391997</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvath, E. et al. Photocatalytic nanowires-based air filter: towards reusable protective masks. Adv. Funct. Mater.30, 2004615. 10.1002/adfm.202004615 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7435547</ArticleId><ArticleId IdType="pubmed">32837497</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson, E. J. et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature584, 430–436. 10.1038/s41586-020-2521-4 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611074</ArticleId><ArticleId IdType="pubmed">32640463</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian, A. et al. Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study. Eur. J. Endocrinol.184, 637–645. 10.1530/EJE-20-1163 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8052516</ArticleId><ArticleId IdType="pubmed">33635829</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi, T. et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature588, 315–320. 10.1038/s41586-020-2700-3 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7725931</ArticleId><ArticleId IdType="pubmed">32846427</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin, J. M. et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front. Public Health8, 152. 10.3389/fpubh.2020.00152 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7201103</ArticleId><ArticleId IdType="pubmed">32411652</ArticleId></ArticleIdList></Reference><Reference><Citation>Peckham, H. et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat. Commun.11, 6317. 10.1038/s41467-020-19741-6 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7726563</ArticleId><ArticleId IdType="pubmed">33298944</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma, L. et al. Evaluation of sex-related hormones and semen characteristics in reproductive-aged male COVID-19 patients. J. Med. Virol.93, 456–462. 10.1002/jmv.26259 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361404</ArticleId><ArticleId IdType="pubmed">32621617</ArticleId></ArticleIdList></Reference><Reference><Citation>Suba, Z. Prevention and therapy of COVID-19 via exogenous estrogen treatment for both male and female patients. J. Pharm. Pharm. Sci.23, 75–85. 10.18433/jpps31069 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32324533</ArticleId></ArticleIdList></Reference><Reference><Citation>Stelzig, K. E. et al. Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol.318, L1280–L1281. 10.1152/ajplung.00153.2020 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7276982</ArticleId><ArticleId IdType="pubmed">32432918</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas, J. M. et al. The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis. Cancer Discov. 4, 1310–1325. 10.1158/2159-8290.CD-13-1010 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4409786</ArticleId><ArticleId IdType="pubmed">25122198</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, M., An, K., Huang, J., Mprah, R. &amp; Ding, H. A novel model based on necroptosis to assess progression for polycystic ovary syndrome and identification of potential therapeutic drugs. Front. Endocrinol. (Lausanne). 14, 1193992. 10.3389/fendo.2023.1193992 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10517861</ArticleId><ArticleId IdType="pubmed">37745699</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenfield, R. L. &amp; Ehrmann, D. A. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr. Rev.37, 467–520. 10.1210/er.2015-1104 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5045492</ArticleId><ArticleId IdType="pubmed">27459230</ArticleId></ArticleIdList></Reference><Reference><Citation>Montopoli, M. et al. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532). Ann. Oncol.31, 1040–1045. 10.1016/j.annonc.2020.04.479 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7202813</ArticleId><ArticleId IdType="pubmed">32387456</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox, C. W. et al. Inflammatory stimuli trigger increased androgen production and shifts in Gene expression in Theca-interstitial cells. Endocrinology160, 2946–2958. 10.1210/en.2019-00588 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6855291</ArticleId><ArticleId IdType="pubmed">31599939</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyrou, I. et al. Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic. BMC Med.18, 220. 10.1186/s12916-020-01697-5 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7360476</ArticleId><ArticleId IdType="pubmed">32664957</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Martinez, C. et al. Transcriptomic clustering of critically ill COVID-19 patients. Eur. Respir. J.10.1183/13993003.00592-2022 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9478362</ArticleId><ArticleId IdType="pubmed">36104291</ArticleId></ArticleIdList></Reference><Reference><Citation>Overmyer, K. A. et al. Large-Scale Multi-omic Analysis of COVID-19 Severity. Cell Syst. 12, 23–40 e27. 10.1016/j.cels.2020.10.003 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543711</ArticleId><ArticleId IdType="pubmed">33096026</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, S. et al. Role and mechanism of mir-335-5p in the pathogenesis and treatment of polycystic ovary syndrome. Transl Res.10.1016/j.trsl.2022.07.007 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35931409</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson, M. D., McCarthy, D. J. &amp; Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics26, 139–140. 10.1093/bioinformatics/btp616 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2796818</ArticleId><ArticleId IdType="pubmed">19910308</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, H. &amp; Boutros, P. C. VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R. BMC Bioinform.12, 35. 10.1186/1471-2105-12-35 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3041657</ArticleId><ArticleId IdType="pubmed">21269502</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa, M. &amp; Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res.28, 27–30. 10.1093/nar/28.1.27 (2000).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC102409</ArticleId><ArticleId IdType="pubmed">10592173</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. &amp; Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res.51, D587–D592. 10.1093/nar/gkac963 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9825424</ArticleId><ArticleId IdType="pubmed">36300620</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk, D. et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res.47, D607–D613. 10.1093/nar/gky1131 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6323986</ArticleId><ArticleId IdType="pubmed">30476243</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res.13, 2498–2504. 10.1101/gr.1239303 (2003).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC403769</ArticleId><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference><Reference><Citation>Bader, G. D. &amp; Hogue, C. W. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinform.4. 10.1186/1471-2105-4-2 (2003).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC149346</ArticleId><ArticleId IdType="pubmed">12525261</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin, C. H. et al. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst. Biol.8 (Suppl 4). 10.1186/1752-0509-8-S4-S11 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4290687</ArticleId><ArticleId IdType="pubmed">25521941</ArticleId></ArticleIdList></Reference><Reference><Citation>Franz, M. et al. GeneMANIA update 2018. Nucleic Acids Res.46, W60–W64. 10.1093/nar/gky311 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6030815</ArticleId><ArticleId IdType="pubmed">29912392</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A.102, 15545–15550. 10.1073/pnas.0506580102 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1239896</ArticleId><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics27, 1739–1740. 10.1093/bioinformatics/btr260 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3106198</ArticleId><ArticleId IdType="pubmed">21546393</ArticleId></ArticleIdList></Reference><Reference><Citation>Newman, A. M. et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat. Biotechnol.37, 773–782. 10.1038/s41587-019-0114-2 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6610714</ArticleId><ArticleId IdType="pubmed">31061481</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia, J., Gill, E. E. &amp; Hancock, R. E. NetworkAnalyst for statistical, visual and network-based meta-analysis of gene expression data. Nat. Protoc.10, 823–844. 10.1038/nprot.2015.052 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25950236</ArticleId></ArticleIdList></Reference><Reference><Citation>Fornes, O. et al. JASPAR 2020: update of the open-access database of transcription factor binding profiles. Nucleic Acids Res.48, D87–D92. 10.1093/nar/gkz1001 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7145627</ArticleId><ArticleId IdType="pubmed">31701148</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, M. et al. Functional characterization of MicroRNA-27a-3p expression in human polycystic ovary syndrome. Endocrinology159, 297–309. 10.1210/en.2017-00219 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29029022</ArticleId></ArticleIdList></Reference><Reference><Citation>Robin, X. et al. pROC: an open-source package for R and S + to analyze and compare ROC curves. BMC Bioinform.12, 77. 10.1186/1471-2105-12-77 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3068975</ArticleId><ArticleId IdType="pubmed">21414208</ArticleId></ArticleIdList></Reference><Reference><Citation>Khateri, S., Mohammadi, H., Khateri, R. &amp; Moradi, Y. The prevalence of underlying diseases and comorbidities in COVID-19 patients; an updated systematic review and meta-analysis. Arch. Acad. Emerg. Med.8, e72 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7588001</ArticleId><ArticleId IdType="pubmed">33134968</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbaro, R. P. et al. Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the extracorporeal life support organization registry. Lancet396, 1071–1078. 10.1016/S0140-6736(20)32008-0 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7518880</ArticleId><ArticleId IdType="pubmed">32987008</ArticleId></ArticleIdList></Reference><Reference><Citation>Yunna, C., Mengru, H., Lei, W. &amp; Weidong, C. Macrophage M1/M2 polarization. Eur. J. Pharmacol.877, 173090. 10.1016/j.ejphar.2020.173090 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32234529</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudnicka, E. et al. Chronic low grade inflammation in pathogenesis of PCOS. Int. J. Mol. Sci.22. 10.3390/ijms22073789 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8038770</ArticleId><ArticleId IdType="pubmed">33917519</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang, J. et al. Enhanced signaling through the TLR9 pathway is associated with resistance to HIV-1 infection in Chinese HIV-1-exposed seronegative individuals. Front. Immunol.11, 1050. 10.3389/fimmu.2020.01050 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7274031</ArticleId><ArticleId IdType="pubmed">32547554</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, H. M., Zhao, C. C., Xie, Q. M., Xu, J. &amp; Fei, G. H. TLR2-melatonin feedback Loop regulates the activation of NLRP3 inflammasome in murine allergic airway inflammation. Front. Immunol.11, 172. 10.3389/fimmu.2020.00172 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7025476</ArticleId><ArticleId IdType="pubmed">32117301</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng, M. et al. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines. Nat. Immunol.22, 829–838. 10.1038/s41590-021-00937-x (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8882317</ArticleId><ArticleId IdType="pubmed">33963333</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan, S. et al. SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-kappaB pathway. Elife10. 10.7554/eLife.68563 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8709575</ArticleId><ArticleId IdType="pubmed">34866574</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu, B. X. et al. Abnormal expression of TLRs may play a role in lower embryo quality of women with polycystic ovary syndrome. Syst. Biol. Reprod. Med.62, 353–358. 10.1080/19396368.2016.1187683 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27367829</ArticleId></ArticleIdList></Reference><Reference><Citation>Ernst, E. H. et al. Distinct expression patterns of TLR transcripts in human oocytes and granulosa cells from primordial and primary follicles. J. Reprod. Immunol.140, 103125. 10.1016/j.jri.2020.103125 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32454326</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan, B. et al. Resveratrol regulates the inflammation and oxidative stress of granulosa cells in PCOS via targeting TLR2. J. Bioenerg Biomembr.. 10.1007/s10863-022-09942-7 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35836030</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonen, M. et al. Rapid and effective vitamin D supplementation may present better clinical outcomes in COVID-19 (SARS-CoV-2) patients by altering serum INOS1, IL1B, IFNg, Cathelicidin-LL37, and ICAM1. Nutrients13. 10.3390/nu13114047 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8618389</ArticleId><ArticleId IdType="pubmed">34836309</ArticleId></ArticleIdList></Reference><Reference><Citation>Rashad, N. M. et al. Intercellular adhesion molecule-1 expression and serum levels as markers of pre-clinical atherosclerosis in polycystic ovary syndrome. J. Ovarian Res.12, 97. 10.1186/s13048-019-0566-5 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6800507</ArticleId><ArticleId IdType="pubmed">31629408</ArticleId></ArticleIdList></Reference><Reference><Citation>Akcali, A. et al. Gingival inflammation and salivary or serum granulocyte-secreted enzymes in patients with polycystic ovary syndrome. J. Periodontol. 88, 1145–1152. 10.1902/jop.2017.170043 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28598286</ArticleId></ArticleIdList></Reference><Reference><Citation>Colicchia, M. et al. S100A8/A9 drives the formation of procoagulant platelets through GPIbalpha. Blood140, 2626–2643. 10.1182/blood.2021014966 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10653093</ArticleId><ArticleId IdType="pubmed">36026606</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan, Z. P. et al. S100A9 activates the immunosuppressive switch through the PI3K/Akt pathway to maintain the immune suppression function of testicular macrophages. Front. Immunol.12, 743354. 10.3389/fimmu.2021.743354 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8576360</ArticleId><ArticleId IdType="pubmed">34764959</ArticleId></ArticleIdList></Reference><Reference><Citation>Ursino, G. et al. S100A9 exerts insulin-independent antidiabetic and anti-inflammatory effects. Sci. Adv.10, eadj4686. 10.1126/sciadv.adj4686 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10796079</ArticleId><ArticleId IdType="pubmed">38170783</ArticleId></ArticleIdList></Reference><Reference><Citation>Manibalan, S. et al. Protein network studies on PCOS biomarkers with s100A8, druggability assessment, and RNA aptamer designing to control its cyst migration effect. Front. Bioeng. Biotechnol.8, 328. 10.3389/fbioe.2020.00328 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7238949</ArticleId><ArticleId IdType="pubmed">32478041</ArticleId></ArticleIdList></Reference><Reference><Citation>Mellett, L. &amp; Khader, S. A. S100A8/A9 in COVID-19 pathogenesis: impact on clinical outcomes. Cytokine Growth Factor Rev.63, 90–97. 10.1016/j.cytogfr.2021.10.004 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8520505</ArticleId><ArticleId IdType="pubmed">34728150</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi, O. S. et al. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science332, 600–603. 10.1126/science.1202947 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3198051</ArticleId><ArticleId IdType="pubmed">21474713</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy, A. et al. Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation. Nat. Immunol.23, 1365–1378. 10.1038/s41590-022-01289-w (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9477731</ArticleId><ArticleId IdType="pubmed">35999394</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, F. et al. Discovery of microglia gonadotropin–releasing hormone receptor and its potential role in polycystic ovarian syndrome. Mol. Med. Rep.27. 10.3892/mmr.2023.12964 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10018280</ArticleId><ArticleId IdType="pubmed">36799164</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie, D. et al. A toll-like receptor-activating, self-adjuvant glycan nanocarrier. Front. Chem.10, 864206. 10.3389/fchem.2022.864206 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9110926</ArticleId><ArticleId IdType="pubmed">35592309</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin, T. M., Burke, S. J., Wasserfall, C. H. &amp; Collier, J. J. Islet beta-cells and intercellular adhesion molecule-1 (ICAM-1): integrating immune responses that influence autoimmunity and graft rejection. Autoimmun. Rev.22, 103414. 10.1016/j.autrev.2023.103414 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10543623</ArticleId><ArticleId IdType="pubmed">37619906</ArticleId></ArticleIdList></Reference><Reference><Citation>Birnhuber, A. et al. Between inflammation and thrombosis: endothelial cells in COVID-19. Eur. Respir. J.58. 10.1183/13993003.00377-2021 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8112008</ArticleId><ArticleId IdType="pubmed">33958433</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith-Norowitz, T. A., Loeffler, J., Norowitz, Y. M. &amp; Kohlhoff, S. Intracellular adhesion molecule-1 (ICAM-1) levels in convalescent COVID-19 serum: a case report. Ann. Clin. Lab. Sci.51, 730–734 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34686518</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan, C. C. et al. Antagonizing the irreversible thrombomodulin-initiated proteolytic signaling alleviates age-related liver fibrosis via senescent cell killing. Cell. Res.33, 516–532. 10.1038/s41422-023-00820-4 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10313785</ArticleId><ArticleId IdType="pubmed">37169907</ArticleId></ArticleIdList></Reference><Reference><Citation>Giri, H. et al. Thrombomodulin is essential for maintaining quiescence in vascular endothelial cells. Proc. Natl. Acad. Sci. U. S. A.118. 10.1073/pnas.2022248118 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7980409</ArticleId><ArticleId IdType="pubmed">33836597</ArticleId></ArticleIdList></Reference><Reference><Citation>Asteris, P. G. et al. Genetic prediction of ICU hospitalization and mortality in COVID-19 patients using artificial neural networks. J. Cell. Mol. Med.26, 1445–1455. 10.1111/jcmm.17098 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8899198</ArticleId><ArticleId IdType="pubmed">35064759</ArticleId></ArticleIdList></Reference><Reference><Citation>van Moorsel, M. V. A. et al. VhH anti-thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow. J. Thromb. Haemost.20, 1213–1222. 10.1111/jth.15674 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9311061</ArticleId><ArticleId IdType="pubmed">35170225</ArticleId></ArticleIdList></Reference><Reference><Citation>Won, T. et al. Endothelial thrombomodulin downregulation caused by hypoxia contributes to severe infiltration and coagulopathy in COVID-19 patient lungs. EBioMedicine75, 103812. 10.1016/j.ebiom.2022.103812 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8756077</ArticleId><ArticleId IdType="pubmed">35033854</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, H. et al. MMP9 protects against LPS-induced inflammation in osteoblasts. Innate Immun.26, 259–269. 10.1177/1753425919887236 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7251795</ArticleId><ArticleId IdType="pubmed">31726909</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranjbaran, J. et al. Matrix metalloproteinases 2 and 9 and MMP9/NGAL complex activity in women with PCOS. Reproduction151, 305–311. 10.1530/REP-15-0340 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26733727</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Y. et al. Pathway and network analyses identify growth factor signaling and MMP9 as potential mediators of mitochondrial dysfunction in severe COVID-19. Int. J. Mol. Sci.24. 10.3390/ijms24032524 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9917147</ArticleId><ArticleId IdType="pubmed">36768847</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelzo, M. et al. Matrix metalloproteinases (MMP) 3 and 9 as biomarkers of severity in COVID-19 patients. Sci. Rep.12, 1212. 10.1038/s41598-021-04677-8 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786927</ArticleId><ArticleId IdType="pubmed">35075175</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaz de Paula, C. B. et al. COVID-19: immunohistochemical analysis of TGF-beta signaling pathways in Pulmonary Fibrosis. Int. J. Mol. Sci.2310.3390/ijms23010168 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8745764</ArticleId><ArticleId IdType="pubmed">35008594</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, X. et al. ITGB2-mediated metabolic switch in CAFs promotes OSCC proliferation by oxidation of NADH in mitochondrial oxidative phosphorylation system. Theranostics10, 12044–12059. 10.7150/thno.47901 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7667693</ArticleId><ArticleId IdType="pubmed">33204328</ArticleId></ArticleIdList></Reference><Reference><Citation>Siekacz, K. et al. Soluble ITGaM and ITGb2 integrin subunits are involved in Long-Term Pulmonary complications after COVID-19 infection. J. Clin. Med.1210.3390/jcm12010342 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9821073</ArticleId><ArticleId IdType="pubmed">36615143</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao, X. et al. Single-cell transcriptome landscape and antigen receptor dynamic during SARS-CoV-2 vaccination. Genes Dis.10, 1675–1686. 10.1016/j.gendis.2022.08.020 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9454148</ArticleId><ArticleId IdType="pubmed">36097543</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Padova, F., Quesniaux, V. F. J. &amp; Ryffel, B. MyD88 as a therapeutic target for inflammatory lung diseases. Expert Opin. Ther. Targets22, 401–408. 10.1080/14728222.2018.1464139 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29658361</ArticleId></ArticleIdList></Reference><Reference><Citation>IRF3. IRF7 require SIRT1 for liquid-liquid phase separation and transactivation of IFN-1. Nat. Immunol.23, 1144–1145. 10.1038/s41590-022-01270-7 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9310678</ArticleId><ArticleId IdType="pubmed">35879453</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, H. et al. S100-A9 protein in exosomes derived from follicular fluid promotes inflammation via activation of NF-kappaB pathway in polycystic ovary syndrome. J. Cell. Mol. Med.24, 114–125. 10.1111/jcmm.14642 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6933366</ArticleId><ArticleId IdType="pubmed">31568644</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, L. et al. Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients. Cell. Mol. Immunol.17, 992–994. 10.1038/s41423-020-0492-x (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332851</ArticleId><ArticleId IdType="pubmed">32620787</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano, R. &amp; Bucci, C. Role of EGFR in the nervous system. Cells9. 10.3390/cells9081887 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7464966</ArticleId><ArticleId IdType="pubmed">32806510</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng, Q. et al. ANP promotes proliferation and inhibits apoptosis of ovarian granulosa cells by NPRA/PGRMC1/EGFR complex and improves ovary functions of PCOS rats. Cell. Death Dis.8, e3145. 10.1038/cddis.2017.494 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5682660</ArticleId><ArticleId IdType="pubmed">29072679</ArticleId></ArticleIdList></Reference><Reference><Citation>Londres, H. D. et al. Blocking EGFR with nimotuzumab: a novel strategy for COVID-19 treatment. Immunotherapy14, 521–530. 10.2217/imt-2022-0027 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8936166</ArticleId><ArticleId IdType="pubmed">35306855</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao, M. et al. Adipose mesenchymal stem cell-derived exosomal microRNAs ameliorate polycystic ovary syndrome by protecting against metabolic disturbances. Biomaterials288, 121739. 10.1016/j.biomaterials.2022.121739 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35987860</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, C. et al. MiRNAs expression profiling of rat ovaries displaying PCOS with insulin resistance. Arch. Gynecol. Obstet.302, 1205–1213. 10.1007/s00404-020-05730-z (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7524818</ArticleId><ArticleId IdType="pubmed">32757043</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian-Min, Y. et al. Combined transcriptomic and metabolomic analysis of women with polycystic ovary syndrome. Dis Mark. 4000424. 10.1155/2022/4000424 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9441417</ArticleId><ArticleId IdType="pubmed">36072900</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, H. &amp; Feng, T. Network-based data analysis reveals ion channel-related gene features in COVID-19: a bioinformatic approach. Biochem. Genet.10.1007/s10528-022-10280-x (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9473477</ArticleId><ArticleId IdType="pubmed">36104591</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng, L. et al. Exercise Training protects Against Heart failure Via Expansion of myeloid-derived suppressor cells through regulating IL-10/STAT3/S100A9 pathway. Circ. Heart Fail.15, e008550. 10.1161/CIRCHEARTFAILURE.121.008550 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34911348</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickenheisser, J. K. et al. Retinoids and retinol differentially regulate steroid biosynthesis in ovarian theca cells isolated from normal cycling women and women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab.90, 4858–4865. 10.1210/jc.2005-0330 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15914525</ArticleId></ArticleIdList></Reference><Reference><Citation>Krause, K. L., Volz, K. W. &amp; Lipscomb, W. N. 2.5 a structure of aspartate carbamoyltransferase complexed with the bisubstrate analog N-(phosphonacetyl)-L-aspartate. J. Mol. Biol.193, 527–553. 10.1016/0022-2836(87)90265-8 (1987).</Citation><ArticleIdList><ArticleId IdType="pubmed">3586030</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>